Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation.

Saved in:
Bibliographic Details
Title: Myeloperoxidase and N-terminal proatrial natriuretic peptide as predictors for atrial fibrillation recurrence in patients undergoing redo ablation.
Authors: Bannehr M; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Georgi C; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Edlinger C; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany.; Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria., Paar V; Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria., Jankowska P; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Lichtenauer M; Department of Cardiology, Clinic of Internal Medicine II, Paracelsus Medical University of Salzburg, Salzburg, Austria., Haase-Fielitz A; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany.; Institute of Social Medicine and Health System Research, Otto von Guericke University Magdeburg, Magdeburg, Germany., Seifert M; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany., Butter C; Department of Cardiology, University Hospital Heart Centre Brandenburg, Brandenburg Medical School (MHB) Theodor Fontane, Bernau/Neuruppin, Germany.; Faculty of Health Sciences, Joint Faculty of the University of Potsdam, the Brandenburg Medical School Theodor Fontane, and the Brandenburg Technical University Cottbus-Senftenberg, Cottbus, Germany.
Source: Heart rhythm O2 [Heart Rhythm O2] 2024 Sep 13; Vol. 5 (11), pp. 770-777. Date of Electronic Publication: 2024 Sep 13 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101768511 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-5018 (Electronic) Linking ISSN: 26665018 NLM ISO Abbreviation: Heart Rhythm O2 Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2666-5018
DOI:10.1016/j.hroo.2024.09.003